Ep 198 – The Founder of Centivax on Being Willing To Hear ‘No’
Ep 198 - The Founder of Centivax on Being Willing To Hear ‘No’
What have you done to make your dreams a reality, peers? For today’s guest it began with a ‘living room-bedroom’. By sub-letting her one bedroom apartment and literally living in her lounge room, Stephanie Wisner was able to fund biotech company BioVenture Advising. Now?
She’s on the Forbes 30 Under 30 list for contributions to healthcare.
In this episode of Peers2Peers, powered by Shopify, Stephanie shares how people’s perceptions can change overnight, what it was like growing up as a half-Korean American, and why we should all be validating ourselves instead of waiting for others.
As entrepreneurs (and especially female entrepreneurs) the thought of hearing a ‘No’ in response to sharing your idea, showing someone a pitch, or finding a mentor can be terrifying. But what if we reframed it?
That’s what this week’s guest, Stephanie Wisner did when she Co-Founded biotech startup, Centivax. Now, Centivax is developing new medicines to treat Covid-19, MRSA, flu and other infectious diseases, but how did she get there?
In this fascinating episode of Peers2Peers, powered by Shopify, Stephanie discusses the upside of getting told ‘no’, how to stay ‘in it’ one you’ve made big decisions, and why the cost of failure isn’t as big as it seems.
Stephanie Wisner is an author and the Co-Founder of Centivax, a biotech startup developing new medicines to treat Covid-19, MRSA, flu and other infectious diseases. The company uses immunoengineering to create “broad-spectrum” treatments and in partnership with the U.S. Navy began clinical trials of its Covid-19 monoclonal antibody candidate earlier this year. She has gained a bachelor’s in Chemistry & Chemical Biology from Cornell University and holds an MBA from University of Chicago, Booth School of Business. Stephanie is also a Forbes 30 Under 30 listee for healthcare.